Table 3 Univariate analysis of the OS, PFS, TRM, and relapse rate in all patients

Age

1.030 (1.002–1.058)

0.036

1.839 (1.037–3.259)

0.037

1.692 (0.885–3.237)

0.112

1.706 (0.689–4.223)

0.248

Gender

0.089 (0.340–1.922)

0.631

0.859 (0.390–1.894)

0.707

0.782 (0.314–1.947)

0.597

1.071 (0.309–3.713)

0.914

Height

1.213 (0.512–2.876)

0.660

0.829 (0.371–1.850)

0.646

1.207 (0.487–2.991)

0.685

0.538 (0.138–2.099)

0.373

Weight

1.162 (0.489–2.758)

0.734

1.410 (0.633–3.144)

0.401

0.971 (0.395–2.391)

0.950

2.259 (0.582–8.769)

0.239

Disease status

1.500 (0.957–2.351)

0.077

1.527 (1.015–2.295)

0.042

1.303 (1.047–1.621)

0.018

1.815 (0.951–3.461)

0.070

Donor type

0.910 (0.473–1.751)

0.777

1.070 (0.559–2.047)

0.839

0.851 (0.440–1.643)

0.630

1.200 (0.393–3.667)

0.748

Mismatched HLA loci

0.943 (0.561–1.587)

0.827

1.146 (0.731–1.797)

0.552

1.036 (0.609–1.764)

0.896

1.626 (0.849–3.113)

0.143

Blood type

1.179 (0.789–1.761)

0.422

1.166 (0.798–1.704)

0.427

1.070 (0.693–1.651)

0.761

0.911 (0.472–1.761)

0.783

MNC count

1.373 (0.583–3.235)

0.468

1.015 (0.456–2.259)

0.972

1.358 (0.551–3.343)

0.506

0.669 (0.173–2.589)

0.561

CD34 + cells count

0.595 (0.200–1.771)

0.351

0.612 (0.229–1.632)

0.326

0.678 (0.225–2.048)

0.491

0.614 (0.130–2.903)

0.539

EBMT risk score

2.653 (1.366 -5.152)

0.004

2.637 (1.438–4.835)

0.002

2.383 (1.219–4.662)

0.011

3.998 (1.291–12.379)

0.016

aGVHD

1.290 (0.548–3.038)

0.560

1.083 (0.494–2.373)

0.843

1.611 (0.648–4.007)

0.305

1.190 (0.344–4.114)

0.783-

cGVHD

0.281 (0.083–0.956)

0.042

0.316 (0.108–0.921)

0.035

0.319 (0.093–1.096)

0.070

0.693 (0.179–2.681)

0.595

Infection

3.887 (1.635–9.239)

0.002

3.100 (1.413–6.803)

0.005

4.944 (1.944–12.574)

0.001

1.922 (0.541–6.827)

0.312-

UCB

0.409 (0.173–0.967)

0.035

0.376 (0.171–0.826)

0.011

0.409 (0.165–1.009)

0.045

0.169 (0.043–0.657)

0.004